Based on ratings from 4 stock analysts, the Innospec Inc stock price is expected to increase by 15% in 12 months. This is calculated by using the average 12-month stock price forecast for Innospec Inc. The lowest target is $122 and the highest is $135. Please note analyst price targets are not guaranteed and could be missed completely.
About 4 Wall Street analysts have assignedIOSP 3 buy ratings, 1 hold ratings, and 0 sell ratings. This means that analysts expect Innospec Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on IOSP. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of IOSP.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Michael Harrison Seaport Global | Neutral | Initiates | Mar 30, 2022 | |
CL King | Buy | Initiates | Sep 4, 2019 | |
KeyBanc | Sector Weight | Downgrade | Apr 12, 2019 | |
Keybanc | Sector Weight | Downgrade | Apr 12, 2019 | |
Michael Sison Keybanc | Overweight | $83 | Maintains | Nov 16, 2018 |
KeyBanc | Overweight | Maintains | Nov 16, 2018 | |
Michael Sison Keybanc | Overweight | $86 | Maintains | Jul 13, 2018 |
KeyBanc | Overweight | Maintains | Jul 13, 2018 | |
Johnson Rice | Buy | Upgrade | Apr 24, 2018 | |
Johnson Rice | Accumulate | Upgrade | Nov 14, 2017 | |
KeyBanc | Overweight | Maintains | Nov 9, 2017 | |
Monness Crespi Hardt | Neutral | Downgrade | Nov 9, 2017 | |
Monness, Crespi, Hardt | Neutral | Downgrade | Nov 9, 2017 | |
Michael Sison Keybanc | Overweight | $77 | Maintains | Nov 9, 2017 |
Monness, Crespi, Hardt | Buy | Upgrade | Aug 22, 2017 | |
Monness Crespi Hardt | Buy | Upgrade | Aug 22, 2017 | |
Monness Crespi Hardt | Neutral | Downgrade | Dec 19, 2016 | |
Monness, Crespi, Hardt | Neutral | Downgrade | Dec 19, 2016 | |
Keybanc | Overweight | Upgrade | Apr 5, 2016 | |
KeyBanc | Overweight | Upgrade | Apr 5, 2016 |
When did it IPO
N/A
Staff Count
2,400
Country
United States
Sector/Industry
Basic Materials/Specialty Chemicals
CEO
Mr. Patrick S. Williams
Market Cap
$2.79B
In 2023, IOSP generated $1.95B in revenue, which was a decrease of -0.76% from the previous year. This can be seen as a signal that IOSP's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Innospec (NASDAQ: IOSP) released its 2023 Sustainability Report, celebrating 25 years of commitment to sustainable business practices.
Why It Matters - Innospec's 2023 Sustainability Report highlights its long-term commitment to sustainability, enhancing its reputation and potentially attracting environmentally conscious investors.
Summary - Innospec (IOSP) reports strong second-quarter results driven by increased volumes in its Performance Chemicals and Fuel Specialties segments.
Why It Matters - Strong results in Performance Chemicals and Fuel Specialties indicate robust demand, potentially boosting Innospec's revenue and profitability, which can positively impact stock performance.
Summary - Innospec, Inc. (NASDAQ:IOSP) held its Q2 2024 Earnings Conference Call on August 7, 2024, at 10:00 AM ET, featuring executives including CFO Ian Cleminson and CEO Patrick Williams.
Why It Matters - The earnings call provides insights into Innospec's financial performance, which can influence stock price and investor sentiment, impacting investment decisions.
Summary - Innospec Inc. reported Q2 2024 results with operating income for Performance Chemicals more than doubling, Fuel Specialties up double digits, and GAAP EPS at $1.24. The company is debt-free with $240M net cash.
Why It Matters - Innospec's strong earnings growth in Performance Chemicals and a debt-free balance sheet indicate financial health, which may attract investors seeking stability and growth potential.
Summary - Innospec (IOSP) reported quarterly earnings of $1.39 per share, exceeding the Zacks Consensus Estimate of $1.37 and up from $1.28 per share a year earlier.
Why It Matters - Innospec's earnings beat expectations and showed year-over-year growth, indicating strong performance and potential for future profitability, which can positively influence investor sentiment.
Summary - Innospec (IOSP) shares rose sharply with above-average trading volume, though recent earnings estimate revisions may not lead to further price increases soon.
Why It Matters - Innospec's share surge and high trading volume indicate increased investor interest, but mixed earnings estimates suggest caution regarding future price growth.